Evogene Ltd (EVGN)
0.6306
-0.03
(-4.27%)
USD |
NASDAQ |
Apr 26, 12:25
Evogene Profit Margin (Quarterly): -1.14K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.14K% |
| September 30, 2023 | -105.8% |
| June 30, 2023 | -1.07K% |
| March 31, 2023 | -978.3% |
| December 31, 2022 | -454.2% |
| September 30, 2022 | -1.40K% |
| June 30, 2022 | -2.83K% |
| March 31, 2022 | -3.49K% |
| December 31, 2021 | -2.37K% |
| September 30, 2021 | -5.04K% |
| June 30, 2021 | -4.60K% |
| March 31, 2021 | -1.98K% |
| December 31, 2020 | -2.31K% |
| September 30, 2020 | -1.51K% |
| June 30, 2020 | -1.42K% |
| March 31, 2020 | -8.30K% |
| December 31, 2019 | -5.24K% |
| September 30, 2019 | -4.36K% |
| June 30, 2019 | -2.13K% |
| March 31, 2019 | -1.07K% |
| December 31, 2018 | -913.5% |
| September 30, 2018 | -1.31K% |
| June 30, 2018 | -1.26K% |
| March 31, 2018 | -1.47K% |
| Date | Value |
|---|---|
| December 31, 2017 | -848.0% |
| September 30, 2017 | -671.7% |
| June 30, 2017 | -402.6% |
| March 31, 2017 | -672.3% |
| December 31, 2016 | -563.0% |
| September 30, 2016 | -332.9% |
| June 30, 2016 | -246.8% |
| March 31, 2016 | -167.3% |
| December 31, 2015 | -222.2% |
| September 30, 2015 | -102.2% |
| June 30, 2015 | -186.4% |
| March 31, 2015 | -126.2% |
| December 31, 2014 | -132.5% |
| September 30, 2014 | -132.1% |
| June 30, 2014 | -82.88% |
| March 31, 2014 | -60.59% |
| December 31, 2013 | -95.56% |
| September 30, 2013 | -54.30% |
| June 30, 2013 | -43.56% |
| March 31, 2013 | -10.42% |
| December 31, 2012 | -15.88% |
| September 30, 2012 | -25.76% |
| June 30, 2012 | -29.14% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-8.30K%
Minimum
Mar 2020
-105.8%
Maximum
Sep 2023
-2.67K%
Average
-2.13K%
Median
Jun 2019
Profit Margin (Quarterly) Benchmarks
| Compugen Ltd | 29.03% |
| Pluri Inc | -4.67K% |
| BioLine Rx Ltd | -289.2% |
| Can Fite Biofarma Ltd | -1.07K% |
| BiomX Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -75.12% |
| Return on Assets | -44.59% |
| Return on Invested Capital | -56.76% |
| Gross Profit Margin (Quarterly) | 31.14% |
| Operating Margin (Quarterly) | -1.32K% |
| Return on Net Operating Assets | -79.20% |